Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma | MicrobiomeTrials← Back to trialsNCT04903678
Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2021-05-01Est. Completion: 2028-05-01
Enrollment target: 18 participants Locations- Fudan Eye & ENT Hospital, Shanghai, China
Other microbiome trials you might be interested in
Retinoblastoma BilateralRetinoblastoma UnilateralRetinoblastoma, ExtraocularRetinoblastoma, RecurrentRetinoblastoma
The goal of this observational study is undertake a detailed phenotypic and genotypic study of patients with ocular and …
Seattle, United StatesEst. completion Jan 1, 2030
RetinoblastomaRefractory
Retinoblastoma (RB) is the most common intraocular malignancy in children, accounting for approximately 11% of all cance…
Shanghai, ChinaEst. completion Sep 30, 2025
RetinoblastomaRetinoblastoma, Recurrent
Retinoblastoma is the most common intraocular malignancy in infancy and childhood,with an estimated 8000 new cases globa…
Shanghai, ChinaEst. completion Dec 31, 2025